Overview
Status
Active
Registry date
2022-04-01
Share capital
5,000.00 PLN
Registered address
ul. Krakowskie Przedmieście 66, 98-300 Wieluń, Poland
Email
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 91 days early.
- 202503/06/2026
- 202403/04/2025
- 202315/02/2024
- 202209/05/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 5.22kMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 382.08MedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 4.84kMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 1.57kMedianUSD 609.79kAverageUSD 11.85m
Industry
Authorized Representatives
Rafał Tadeusz Orzechowski – Management Board Member
Serdar Yurtalanoğlu – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Rafał Tadeusz Orzechowskiage 43 | 50 | $675.31 | 50% |
Serdar Yurtalanoğluage 48 | 50 | $675.31 | 50% |
The articles of association require board approval for share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Beyond Medical Aesthetics Polskasp. z o.o. | $13,696.94 | bmapolska.pl | ||
| Aptekssp. z o.o. | $13,537.42 | apteks.com | ||
| Grupa Medicalsp. z o.o. | $12,999.72 | grupamedical.pl | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu | ||
| Polidental Tradesp. z o.o. | $9,409.06 | poli.dental | ||
| Jacek Waksmundzki Trust 2S.K.A. | $5,769.53 | trust.pl | ||
| Endolink PharmaS.A. | $5,022.60 | endolink.pl | ||
| Zdrowie ze Znakiem Kangurasp. z o.o. | $4,586.12 | zdrowie-kangur.pl | ||
| Vetarissp. z o.o. | $4,335.41 | vetaris.pl | ||
| BIATsp. z o.o. | $2,327.20 | biat.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-16 | Name change (Ewolma → Avex Group) | |
| 2026-09-16 | Address change (Ul. Kpt. Pilota Żwirki 18/1, 90-450, Łódź → Ul. Krakowskie Przedmieście 66, 98-300, Wieluń) | |
| 2022-04-01 | Entered in the register |
FAQ
The main business activity of Avex Group focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on April 1, 2022.
The headquarters is located at: ul. Krakowskie Przedmieście 66, 98-300 Wieluń.
The management board consists of: Olha Melnyk (Member of the Management Board) and Svitlana Melnyk (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 5,222, representing a decrease of 77.5% compared to 2024.
Yes, in 2025 the company achieved a net profit of USD 382.
Last updated: 2026-10-03